- Home
- QRVO vs LNTH Comparison
QRVO vs LNTH Comparison
Compare QRVO & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QRVO
- LNTH
- Stock Information
- Founded
- QRVO 1957
- LNTH 1956
- Country
- QRVO United States
- LNTH United States
- Employees
- QRVO N/A
- LNTH N/A
- Industry
- QRVO Semiconductors
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- QRVO Technology
- LNTH Health Care
- Exchange
- QRVO Nasdaq
- LNTH Nasdaq
- Market Cap
- QRVO 6.6B
- LNTH 7.5B
- IPO Year
- QRVO 1997
- LNTH 2015
- Fundamental
- Price
- QRVO $57.63
- LNTH $101.32
- Analyst Decision
- QRVO Hold
- LNTH Strong Buy
- Analyst Count
- QRVO 19
- LNTH 6
- Target Price
- QRVO $91.65
- LNTH $129.83
- AVG Volume (30 Days)
- QRVO 3.4M
- LNTH 830.2K
- Earning Date
- QRVO 04-29-2025
- LNTH 05-01-2025
- Dividend Yield
- QRVO N/A
- LNTH N/A
- EPS Growth
- QRVO N/A
- LNTH N/A
- EPS
- QRVO 0.28
- LNTH 4.36
- Revenue
- QRVO $3,790,485,000.00
- LNTH $1,533,910,000.00
- Revenue This Year
- QRVO $0.12
- LNTH $5.74
- Revenue Next Year
- QRVO N/A
- LNTH $12.27
- P/E Ratio
- QRVO $203.82
- LNTH $23.24
- Revenue Growth
- QRVO 9.51
- LNTH 18.32
- 52 Week Low
- QRVO $49.46
- LNTH $61.47
- 52 Week High
- QRVO $130.99
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- QRVO 40.21
- LNTH 55.37
- Support Level
- QRVO $54.49
- LNTH $91.65
- Resistance Level
- QRVO $59.86
- LNTH $104.00
- Average True Range (ATR)
- QRVO 5.01
- LNTH 5.54
- MACD
- QRVO -0.37
- LNTH 0.34
- Stochastic Oscillator
- QRVO 33.77
- LNTH 85.89
About QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.